10:06
2026-07-01
cryptobriefing.com
generative-ai
Eli Lilly invests $40M in Absci for AI-designed injectable antibody ABS-201
Eli Lilly invested $40 million in Absci Corporation to advance ABS-201, an AI-designed injectable antibody targeting hair loss and endometriosis. The investment was part of a $100 million equity round…